Startups attacking the two bottlenecks in biological crop protection — the active ingredients, and the infrastructure to deploy them. The agrochemical industry has run on synthetic chemistry for a hundred years. That’s changing faster than...
Latest articles
A look at the themes, tensions, and quiet shifts shaping food and agriculture innovation this year. The annual circuit of food and ag conferences can blur together after a while — the same buzzwords, the same stage formats, the same optimistic...
HarvestR Ancient Organics Bioscience LiveGrow Bio The economics of pest and disease management are shifting. Regulatory pressure on synthetic chemistry is tightening. Resistance to insecticides, fungicides, and herbicides is accelerating. And...
AI is accelerating the innovation cycle in ways most systems weren’t designed to accommodate. New ideas can be generated, tested, recombined, and refined at a pace that compresses what used to take months into days, sometimes hours. That speed is...
Nutrition guidance is no longer a single steady target. It’s becoming a moving set of constraints, driven by shifting federal dietary messaging, school-meal standards that translate guidance into procurement specs, and potential labeling changes...
The journey from scientific discovery to industry adoption is rarely straightforward. Nowhere is this more evident than in food science, where breakthrough ideas—new sustainable materials, processing innovations, or safety technologies—often...
Public–private collaboration is often discussed as a pipeline problem: universities need more industry opportunities, companies need more academic partners, and everyone needs a better matchmaking mechanism. But in conversations with research...
TTFVS tracks how long it takes—from the moment you kick off a search—to reach the first solution that clearly meets your viability bar. It’s a practical, leading indicator for how smoothly your partnering motion is running. It’s not the only thing...
Why Leading Indicators Are the Key to More Predictable, Efficient Innovation Most R&D organizations still measure performance with lagging indicators—launches, patents, revenue. Those matter, but they arrive too late. By the time a project...
Bayer Pharma has named Rege Nephro, a clinical-stage biotech startup from Japan and NXI Therapeutics, an immunotherapy startup based in Switzerland, as the first companies selected for its new Bayer Co.Lab Connect program: an initiative designed to...